Impax Asset Management Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,000
Closed -$13M 348
2024
Q1
$13M Buy
40,000
+2,000
+5% +$491K 0.05% 149
2023
Q4
$7.24M Hold
38,000
0.03% 193
2023
Q3
$7.57M Buy
+38,000
New +$8.99M 0.03% 182
2023
Q2
Sell
-17,500
Closed -$3.79M 400
2023
Q1
$3.79M Buy
+17,500
New +$3.41M 0.02% 207

Other funds holding SWAV

Impax Asset Management Group's SWAV Position: Q2 2024 in Review

Impax Asset Management Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 40,000 shares — an estimated $13M sold.

Impax Asset Management Group first reported a position in SWAV in Q1 2023 and held it in 4 quarters. The position peaked at $13M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Impax Asset Management Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 40,000 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $13M.
  • Impax Asset Management Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Impax Asset Management Group's Shockwave Medical, Inc. Common Stock position peaked at $13M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Impax Asset Management Group's 13F filing for Q2 2024, filed 5 Aug 2024.